Form 4 for LUNG Pulmonx Corp
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001209191-23-057506 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-05 | 2023-12-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $10.34 | -6,676 | 1.17M | -0.6% | -$69.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | S | D | 4,045 | $10.34 | 1,161,344 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-01 | S | D | 1,040 | $10.34 | 1,166,980 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-01 | S | D | 1,591 | $10.34 | 1,165,389 | D | — | — |